Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival

Figure 4

Kaplan-Meier survival analysis of the patient cohort: mean short-term survival was significantly longer in group with treatment duration >18 days compared with those less than 18 days treated: 29.2 days [95% CI 28.4–30.0] versus 23.4 days [95% CI 20.9–25.9] (treatment days ≥ 18 versus treatment days < 18 days, log-rank test, ).